BEDFORD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today ...

From Ironmouse to IShowSpeed, content creators of all stripes are finding success as streamers. Professional streamers often have elaborate setups that can cost thousands of dollars. You may not use ...

A new laptop feels like a fresh digital start: fast, clean, and ready for anything. But before you dive in, it’s wise to perform a quick system check, because many devices come with unnecessary ...

Setting up a dual monitor system to extend your screen and optimize computer display settings for a more productive and efficient workspace. Pixabay, DaveMeier Setting up two monitors on a single ...

Prince Andrew has announced he will no longer use his title of Duke of York and several royal honours, following ongoing scrutiny of his ties to Jeffrey Epstein and renewed public pressure. Although ...

I truly believe that if your setup is good, you’ll not only hit the ball more consistently but your misses will also be much more playable. In fact, you can often tell where a shot is going before the ...

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...

Bristol Myers Squibb has agreed to buy privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash in a deal that bolsters the drugmaker's cell-therapy portfolio. Bristol Myers ...

Bristol Myers Squibb (NYSE:BMY) has agreed to acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash. Orbital Therapeutics is advancing a new generation of RNA ...

Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products facing ...